Glycemic control in patients with insulinoma

被引：33

作者：

Matej, Agata ^{[1
]}

Bujwid, Hanna ^{[2
]}

Wronski, Jakub ^{[3
]}

机构：

[1] Prof W Orlowski Hosp, Warsaw, Poland

[2] Wolski Hosp, Warsaw, Poland

[3] Warsaw Med Univ, Dept Disaster Med, Warsaw, Poland

来源：

HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM | 2016年 / 15卷 / 04期

关键词：

Insulinoma; Glycemic control; Hypoglycemia; Hyperinsulinism; Pharmacotherapy; PANCREATIC NEUROENDOCRINE TUMORS; ENETS CONSENSUS GUIDELINES; MALIGNANT INSULINOMA; METASTATIC INSULINOMA; MEDICAL-TREATMENT; MANAGEMENT; HYPOGLYCEMIA; EVEROLIMUS; DIAZOXIDE; THERAPY;

D O I：

10.14310/horm.2002.1706

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Insulinoma is the most common neuroendocrine tumor of the pancreas. Surgical management of insulinomas is considered to be the only curative method. However, effective glycemic control preoperatively and in unresectable insulinomas remains a significant issue. Hyperinsulinism, occurring as a result of the hormone-secreting tumor, leads to life-threatening hypoglycemia episodes which require urgent medical treatment. This article discusses current management of hypoglycemia in insulinoma patients, including: education and lifestyle modifications, pharmacotherapy (diazoxide, somatostatin analogs, mTOR inhibitor - everolimus), cytoreductive methods and continuous glucose monitoring systems.

引用

页码：489 / 499

页数：11

共 50 条

[1] Glycemic control in patients with insulinoma
Agata Matej
Hanna Bujwid
Jakub Wroński
Hormones, 2016, 15 : 489 - 499
[2] Everolimus Dramatically Improves Glycemic Control in Unresectable Metastatic Insulinoma: A Case Report
Asayama, Masako
Yamada-Murano, Toko
Hara, Hiroki
Ooki, Akira
Kurosumi, Masafumi
Yamaguchi, Kensei
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (02) : 186 - 190
[3] Approach to the Patient: Insulinoma
Hofland, Johannes
Refardt, Julie C.
Feelders, Richard A.
Christ, Emanuel
de Herder, Wouter W.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (04): : 1109 - 1118
[4] Glycemic control in patients with type 2 diabetes mellitus in Spain
Perez, A.
Mediavilla, J. J.
Minambres, I.
Gonzalez-Segura, D.
REVISTA CLINICA ESPANOLA, 2014, 214 (08): : 429 - 436
[5] A case of malignant insulinoma: successful control of glycemic fluctuation by replacing octreotide injections with octreotide LAR injections
Okamoto, Masahide
Kishimoto, Miyako
Takahashi, Yoshihiko
Osame, Keiichiro
Noto, Hiroshi
Yamamoto-Honda, Ritsuko
Kajio, Hiroshi
Tokuhara, Makoto
Edamoto, Yoshihiro
Endo, Hisako
Igari, Toru
Kubota, Kazuo
Noda, Mitsuhiko
ENDOCRINE JOURNAL, 2013, 60 (08) : 951 - 957
[6] Time and degree of glycemic derangement are associated with increased modality in trauma patients in the setting of tight glycemic control
Corneille, Michael G.
Villa, Celina
Wolf, Steven
Michalek, Joel E.
Jung, Inkyung
Wade, Charles E.
Myers, John G.
Dent, Daniel L.
Mueller, Deborah
Stewart, Ronald M.
AMERICAN JOURNAL OF SURGERY, 2010, 200 (06): : 832 - 837
[7] Peptide Receptor Radionuclide Therapy Is Effective for Clinical Control of Symptomatic Metastatic Insulinoma: A Long-Term Retrospective Analysis
Friebe, Liene
Freitag, Martin T.
Braun, Martin
Nicolas, Guillaume
Bauman, Andreas
Bushnell, David
Christ, Emanuel
Wild, Damian
JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (02) : 228 - 235
[8] Glycemic Control for Postoperative Pediatric Cardiac Patients
Preissig, Catherine M.
Rigby, Mark R.
Maher, Kevin O.
PEDIATRIC CARDIOLOGY, 2009, 30 (08) : 1098 - 1104
[9] Optimal glycemic control in neurocritical care patients
Federico Bilotta
Giovanni Rosa
Critical Care, 16
[10] Managing Hypoglycaemia in Patients With Insulinoma-A Tertiary Centre Experience and Review of the Literature
Howarth, Sophie
Ho, Tak-Wai
Wimbury, James
Casey, Ruth
CLINICAL ENDOCRINOLOGY, 2025, 102 (03) : 344 - 354

← 1 2 3 4 5 →